Specialties:
Most Popular Oncology Reports:
Oncology
Oncology is the study of cancer. Surveys and online discussions in this area cover subjects such as trends in use of Erythropoiesis-Stimulating Agents (ESAs); an evaluation of radiation therapy equipment; treatment trends of various chemotherapy agents (Revlimid, Avastin, Mozobil, etc.), and specific treatment evaluations of cancer types.Reports that are less than a year old are highlighted in yellow. When you select the report title you will be directed to the report abstract and provided a link for purchasing the report. Reports that are over a year old are free of charge and are not highlighted. When you select the report name you will be taken directly to the report.
| Report Name | Report Type | Specialty | Publish Date | |
|---|---|---|---|---|
| Market Potential of ACAPODENE for ADT-Associated Osteoporosis | Discussion | Oncology, Surgery | Apr 15, 2008 | PAID REPORT |
| To conduct a panel discussion among urologists who specialize in the treatment of prostate cancer to examine the phase III clinical data recently released about ACAPODENE® (toremifene citrate) and evaluate how this drug might influence clinical practice if it were to receive FDA approval. ... | ||||
| Avastin and the AVADO Trial Survey | Survey | Oncology | Feb 21, 2008 | PAID REPORT |
| To conduct a brief survey among oncologists who are currently using Avastin to treat breast cancer to gauge their opinion of the AVADO trial and assess its potential impact on the FDA review of Avastin in the treatment of breast cancer that is to occur on February 23, 2008. To... | ||||
| Post- American Society of Hematology Annual Meeting (ASH) Survey 2007 | Survey | Oncology | Feb 8, 2008 | PAID REPORT |
| To determine trends and practices in the treatment of multiple myeloma following data presentations at American Society of Hematology in 2007. Specifically to: Understand multiple myeloma treatment background. Analyze treatment trends for SCT and non-SCT... | ||||
| Multiple Myeloma: Revlimid in the European Market | Survey | Oncology | Jan 29, 2008 | PAID REPORT |
| To understand current practices and trends regarding the use of newly approved agents in patients with multiple myeloma (MM) and the impact of newly approved Revlimid in this market. Additionally to: Determine current practice patterns in MM Quantify usage of... | ||||
| Multiple Myeloma: Revlimid in the U.S. Market | Survey | Oncology | Jan 29, 2008 | PAID REPORT |
| To understand current practices and trends regarding the use of newly approved agents in patients with multiple myeloma (MM). Determine current practice patterns in MM. Quantify usage of newly indicated agents in MM patients. Gain understanding... | ||||
| Radiation Oncology Equipment Marketplace | Discussion | Oncology | Dec 9, 2007 | PAID REPORT |
| To conduct a panel discussion on radiation oncology equipment among twelve radiation oncologists. Evaluate the market outlook for Varian Medical, TomoTherapy, Accuray, and Elekta Treatment panning software: Varian�s Volumetric Modulated Arc Therapy (VMAT) vs.... | ||||
| Radiation Oncology Cyberknife Product Assessment and Market Trends | Discussion | Oncology, Rheumatology | Dec 3, 2007 | PAID REPORT |
| To conduct a panel discussion among radiation oncologists to understand current uses of Accuray�s Cyberknife � , the investment in and financing of the equipment, and the marketplace for stereotactic radiosurgery equipment. Examine current uses of Cyberknife � in the head and... | ||||
| Avastin: Trends in Use in Breast Cancer | Survey | Oncology | Nov 18, 2007 | PAID REPORT |
| To understand current practices and trends in the treatment of metastatic breast cancer with Avastin by conducting a survey of oncologists. Quantify usage of current treatment regimens at various stages of treatment Explore specific drug combinations ... | ||||
| Mozobil in Stem Cell Transplantation | Discussion | Oncology | Oct 31, 2007 | PAID REPORT |
| Panel Intelligence engaged a set of opinion-leading clinicians and researchers in hematology/oncology in a discussion designed to: Assess awareness and general impressions of Genzyme�s Mozobil Level of excitement surrounding this agent ... | ||||
| Erythropoiesis-Stimulating Agents (ESAs): Trends in Use in Oncology (Part 2) | Survey | Oncology | Oct 2, 2007 | PAID REPORT |
| To understand current practices and trends regarding the use of erythropoiesis-stimulating agents (ESA) for chemotherapy-induced anemia (CIA) patients and future projected use of ESAs based on new Medicare policy. Additionally: Anticipate the impact of... | ||||
| Non-Small Cell Lung Cancer: Avastin Trends in Use | Survey | Oncology | Sep 14, 2007 | PAID REPORT |
| To understand current practices and trends in the treatment of non-small cell lung cancer with Avastin, including treatment dose and duration of treatment, by conducting a survey of oncologists. Specifically: Determine current levels of Avastin use compared... | ||||
| Radiation Therapy: Intensity-Modulated Market Assessment | Discussion | Oncology | Sep 13, 2007 | PAID REPORT |
| To engage a panel of radiation oncologists in order to understand how specific manufacturers (Varian, TomoTherapy, Elekta, Accuray) compare in the intensity-modulated radiation therapy (IMRT) and stereotactic markets. Specifically: Understand current use of IMRT and... | ||||
| Digital Mammography Market Evaluation | Discussion | Oncology, Womens Health | Sep 13, 2007 | PAID REPORT |
| To conduct a panel discussion among radiologists to understand current utilization of digital mammography, explore the competitive marketplace, and compare product options. Assess the current use of digital mammography and the impact of the DMIST trial Review the... | ||||
| Stereotactic Radiosurgery: Market Assessment | Discussion | Oncology | Sep 4, 2007 | PAID REPORT |
| Engage a panel of radiation oncologists to understand how specific manufacturers (Varian, TomoTherapy, Elekta, Accuray) compare in the stereotactic market Understand current use of stereotactic radiosurgery (SRS) Identify the major players and most... | ||||
| Partial Breast Irradiation: Market Assessment | Discussion | Oncology | Jul 14, 2007 | PAID REPORT |
| To understand the market dynamics in partial breast irradiation and the competitive advantages/disadvantages between SenoRx�s Multi-Lumen Radiation Balloon and other products including Cytyc�s MammoSite�. Assess the decision-making process by determining who is involved and what... | ||||
| ASCO 2007: Leadership Summit on NSCLC | Discussion | Oncology | Jun 14, 2007 | PAID REPORT |
| To review information presented at ASCO 2007 and discuss up-to-date treatment practices for non-small cell lung cancer (NSCLC). Survey choices for first-, second-, and third-line therapy for MM including the use of: o Bevacizumab (Genentech�s Avastin �... | ||||
| American Society of Clinical Oncology 2007 Leadership Summit: Hematologic Malignancies | Discussion | Oncology | Jun 14, 2007 | PAID REPORT |
| To review information presented at ASCO 2007 and discuss up-to-date treatment practices for multiple myeloma (MM), non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL) and myelodysplastic syndromes (MDS). Survey choices for first-, second-, and third-line therapy for... | ||||
| Erythropoietin (EPO) Stimulating Agents: Impact of Proposed CMS Guidelines | Survey | Oncology | Jun 13, 2007 | PAID REPORT |
| To quantify the potential impact of the CMS proposal on ESA usage by surveying a set of oncologists with large practices. Determine current practices in ESA treatment by patient type and cancer type. Estimate potential impact overall and by patient type and... | ||||
| Multiple Myleoma Therapy: Market Assessment | Discussion | Oncology | May 14, 2007 | FREE |
| To understand multiple myeloma treatment practices and trends, including what determines therapy choice, importance and scale of free goods programs and trends in treatment. Topics covered include: Use of specific agents � Revlimid� (lenalidomide), Velcade� (bortezomib), ... | ||||
| Revlimid: Trends in Use (Wave 2) | Survey | Oncology | Apr 29, 2007 | FREE |
| To track changes between Wave 1 and Wave 2 regarding the current and potential use of Revlimid. Specific objectives include: Examine the current uses and impressions of Revlimid Predict future use of Revlimid for different lines of treatment ... | ||||
| Radiosurgery and Radiotherapy Systems: US Market Assessment | Survey | Neuro, Oncology | Apr 29, 2007 | FREE |
| To understand current and future usage of radiosurgical systems, with a specific focus on the Accuray CyberKnife, by surveying a set of physicians and hospital administrators. Gauge awareness, perceptions and experience levels among physicians and hospital administrators with a... | ||||
| Erythropoietin (EPO) Stimulating Agents: Trends in Use in Oncology | Discussion | Oncology | Mar 19, 2007 | FREE |
| Panel Intelligence engaged a panel of community-based oncologists in an online, interactive discussion designed to: Understand how EPO is used in oncology. Impact on use of EPO in oncology as the U.S. Food and Drug Administration review of the safety and... | ||||
| Multiple Myeloma: US Market Assesment | Survey | Oncology | Mar 14, 2007 | FREE |
| To understand current practices and trends in the treatment of multiple myeloma (MM) as they relate to stem cell transplantation (SCT) and the use of biologic and other drug therapies by conducting a survey of community-based hematologist/oncologists. Determine current levels of... | ||||
| Myelodysplastic Syndrome Discussion | Discussion | Oncology | Apr 4, 2006 | FREE |
| Discuss current management strategies for MDS and determine unmet needs for this population Gather feedback regarding recently introduced and upcoming treatments Explore alternative indications and/or patient populations/sub-types for new treatments Determine the impact new products will... | ||||
 about us contact us |
 |
| © Panel Intelligence, LLC. 1999-2008. All rights reserved. A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR) Privacy Policy |